KCL CfAD @kclcfad

The Centre for Affective Disorders @KingsIoPPN kcl.ac.uk/research/centr… London, England Joined December 2016

Tweets

288
Followers

540
Following

499
Likes

556

Tony Cleare @TCleare

6 months ago

Published today in Lancet Psychiatry, after 7 years of hard labour... the first long-term head-to-head comparison of two augmentation treatments in treatment resistant depression. Clinical and cost-effectiveness of lithium versus quetiapine augmentat... sciencedirect.com/science/articl…

11 32 128 17K 57

Tony Cleare @TCleare

2 years ago

Fantastic setting for a conference in Milan, and (if I do say so myself) a wonderful academic event! See you for ISAD2024 and 2025! @ISADTweet

KCL CfAD @kclcfad

2 years ago

Fantastic setting for a conference in Milan, and (if I do say so myself) a wonderful academic event! See you for ISAD2024 and 2025! @ISADTweet

0 1 5 645 1

Download Image

0 1 8 431 0

KCL CfAD @kclcfad

2 years ago

@kclcfad CRiB2 researchers @kalfas_michael and @Rosie_H_Taylor presented preliminary findings regarding the discrepancy between subjective and objective reports of cognitive performance at #ISAD2023 The implications for cognitive remediation therapy were discussed

0 3 8 2K 0

Download Image

KCL CfAD @kclcfad

2 years ago

It is well worth zooming in to the results, they are very interesting Other authors: Eirini Flouri, Steven Papachristou

0 0 3 128 0

KCL CfAD @kclcfad

2 years ago

Francesca Bentivegna reported from #ISAD2023 for @Mental_Elf with vigour and dedication (thank you so much!) as well as presenting her own interesting findings (from @UCL_IOE_PHD and @CUBIC_UCL): Trajectories of Self-Regulation in Childhood and Reward Processing in Adolescence

3 3 9 2K 0

Download Image

KCL CfAD @kclcfad

2 years ago

A wonderful poster (take a closer look at the infographics!) of a systematic review from the @kclcfad team The Effects of single dose and repeated dose of Ketamine on cognition in Treatment-Resistant Depression Fatema Alhayyas, @Laithalexander and @MarioJuruena #ISAD2023

0 2 6 949 1

Download Image

The Mental Elf @Mental_Elf

2 years ago

3) Dr Clare Dolman @dolman_clare – Patient Advocate Award 🏆 #ISAD2023

1 2 3 251 0

Download Image

The Mental Elf @Mental_Elf

2 years ago

1) Dr Rebecca Strawbridge @Strawbr1 – Early Career Award Winner 🏆 #ISAD2023

1 2 8 1K 0

Download Image

The Mental Elf @Mental_Elf

2 years ago

The time to say bye has come, as the Closing Ceremony took place at #ISAD2023! But first, @ISADTweet President Prof @TCleare gave the prizes 🏆 to the Award winners for their outstanding work. Long applauses followed for the awardees – huge congrats everyone! 👏👏👏 THREAD 👇

2 1 7 2K 1

KCL CfAD @kclcfad

2 years ago

@MarioJuruena @mehta_mitul72 Prof Allan Young and Prof Eric Ruhe join the discussion: which ketamine admin route is the fastest? the most cost-effective? the most effective on suicidal ideation? #ISAD2023 @ISADTweet

0 0 1 157 0

KCL CfAD @kclcfad

2 years ago

@MarioJuruena @mehta_mitul72 What predicts antidepressant response to #ketamine ? Prof Rodrigo Machado-Vieira's outstanding presentation spans from clinical variables (BMI, family Hx of ETOH abuse) to biomarkers (D-serine, BDNF, adipokines...) What do you think is the strongest predictor? 💉💊 #ISAD2023

1 0 1 179 0

KCL CfAD @kclcfad

2 years ago

The chair Brenda Penninx @brenda_penninx asks would TRD be better described as ‘medication treatment resistant depression’ @_Luca_Sforzini agrees although highlights how difficult it is to standardise psychotherapy and draw clear conclusions re mean response #ISAD2023

0 1 1 281 0

Download Image

KCL CfAD @kclcfad

2 years ago

The conference is soon to end… but first, Luca Sforzini @_Luca_Sforzini has just made an important closing point about the diverse terminology and assessments for a single construct during his talk on a Delphi-method-based consensus guideline for definition of TRD #ISAD2023

1 3 5 873 1

Download Image

KCL CfAD @kclcfad

2 years ago

@MarioJuruena @mehta_mitul72 @MarioJuruena is the Lead Consultant at the Maudsley Advanced Treatment Service (MATS), providing cutting-edge treatments for complex #affectivedisorders, including subcutaneous #ketamine and neuromodulation techniques #ISAD2023

0 1 4 191 1

Download Image

KCL CfAD @kclcfad

2 years ago

Anna Tröger (a @kclcfad PhD student) presents her poster, a meta-analysis and meta-regression reporting that: Baseline depression severity does not moderate the effects of psychotherapy compared with pharmacotherapy for depression. #ISAD2023

0 4 9 1K 0

Download Image

KCL CfAD @kclcfad

2 years ago

@MarioJuruena @mehta_mitul72 Fascinating talk by Prof @mehta_mitul72 on ketamine's #reward circuitry modulation 🧠 More research on ketamine and reward in #bipolar disorder is needed ‼️

0 0 3 96 0

Download Image

KCL CfAD @kclcfad

2 years ago

Here is Jawaher S. Alnassar presenting her poster on ‘The impact of early life stress on adulthood personality traits.’ Other authors included @MarioJuruena @AdamPerkinsPhD and Professor Allan. H Young

0 1 4 1K 0

Download Image

KCL CfAD @kclcfad

2 years ago

@MarioJuruena @mehta_mitul72 Prof @mehta_mitul72 is Head of the Neuropharmacology Group and Section in the Department of Neuroimaging at KCL and Director of the IoPPN Centre for Innovative Therapeutics

0 0 3 112 1

Download Image

KCL CfAD @kclcfad

2 years ago

The closing slide from Yuri Milaneschi’s @YMilaneschi talk today: Immuno-Metabolic Depression: Bringing precision psychiatry from research to the clinics #ISAD2023

0 1 13 3K 0

Download Image

KCL CfAD @kclcfad

2 years ago

Dr Tsapekos, Dr Strawbridge, @Strawbr1 & Professor Young present a poster at #ISAD2033 Accounting for premorbid IQ increases the proportion of cognitively impaired BD patients. This can have implications for screening in cognition trials and delivering cognitive interventions